A Qualitative, Multiperspective Inquiry of Multiple Sclerosis Telemedicine in the United States

• Published in: International journal of MS care 2022-11, Vol.24 (6), p.275-281
• Main Authors: Roth, Erin G, Minden, Sarah L, Maloni, Heidi W, Miles, Zipporah J, Wallin, Mitchell T
• Format: Article
• Language: English
• ISSN: 1537-2073
• DOI: 10.7224/1537-2073.2021-117

Telemedicine has expanded access to high-quality, appropriate, and affordable health care for people with multiple sclerosis (MS). This study explored how the expansion of MS telemedicine is perceived and experienced by people with MS, health care providers (HCPs), and payers and policy experts (PYs). Forty-five semistructured interviews with 20 individuals with MS, 15 HCPs, and 10 PYs were conducted between September 2020 and January 2021. The interviews were recorded on a televideo platform, transcribed, and analyzed for themes using qualitative data software. Interviews revealed the following 4 themes. : Telemedicine increases access and convenience. Technical challenges were the most cited downside to telemedicine. : Confidence in MS care via telemedicine varies. Virtual "house calls" have clinical benefits. : Reimbursement parity is critical to utilization and expansion of telemedicine. Stakeholders are hopeful and fearful as infrastructure and business models begin to shift. : The familiar structure of the office visit is currently absent in telemedicine. Telemedicine visits need more intentionality from both providers and patients. Telemedicine is an efficient, convenient way to deliver and receive many aspects of MS care. To expand telemedicine care, many HCPs need more training and experience, people with MS need guidance to optimize their care, and PYs in the United States need to pass legislation and adjust business models to incorporate benefits and reimbursement for telemedicine health in insurance plans. The future is promising for the ongoing use of telemedicine to improve MS care, and stakeholders should work to preserve and expand the policy changes made during the COVID-19 pandemic.